Information  X 
Enter a valid email address

Oxford Biodynamics PLC GBP0.01 (OBD)

Date Time Source Announcement
11 Dec 2018 7:00 am
RNS
Final Results
03 Dec 2018 10:10 am
RNS
Total Voting Rights
23 Nov 2018 7:00 am
RNS
Notice of results for year ended 30 Sept 2018
12 Nov 2018 7:00 am
RNS
Collaboration into identifying diagnosis of Autism
08 Nov 2018 7:00 am
RNS
OBD signs fifth collaboration agreement
07 Nov 2018 7:00 am
RNS
Study published in Faculty of 1000 Research
06 Nov 2018 7:00 am
RNS
Issue of Equity
01 Nov 2018 5:17 pm
RNS
Total Voting Rights
02 Oct 2018 7:00 am
RNS
Issue of Equity
26 Sep 2018 7:00 am
RNS
Issue of Equity
18 Sep 2018 7:00 am
RNS
Consortium with OBD receives ?4m Horizon 2020 fund
04 Sep 2018 10:03 am
RNS
Total Voting Rights
30 Aug 2018 2:57 pm
RNS
Holding(s) in Company
29 Aug 2018 4:52 pm
RNS
Holding(s) in Company
  4:48 pm
RNS
Holding(s) in Company
  4:47 pm
RNS
Holding(s) in Company
  4:46 pm
RNS
Holding(s) in Company
  4:43 pm
RNS
Holding(s) in Company
22 Aug 2018 7:00 am
RNS
Chinese Investment Group Takes Stake in OBD
19 Jul 2018 7:00 am
RNS
Grant of Canadian patent for EpiSwitch platform
17 Jul 2018 7:00 am
RNS
OBD presents latest EpiSwitch data at ASH Summit
02 Jul 2018 5:50 pm
RNS
Total Voting Rights
26 Jun 2018 7:00 am
RNS
ALS study published in peer reviewed journal
19 Jun 2018 7:00 am
RNS
Issue of Equity
22 May 2018 7:00 am
RNS
Interim Results for the Period Ended 31 March 2018
01 May 2018 7:00 am
RNS
Total Voting Rights
17 Apr 2018 7:00 am
RNS
Notice of Interim Results
05 Apr 2018 11:41 am
RNS
Issue of Equity
28 Mar 2018 7:00 am
RNS
Publication in Journal of Translational Medicine
19 Mar 2018 7:00 am
RNS
PDMR Dealing/Grant of Share Options
16 Mar 2018 7:00 am
RNS
ALS biomarker data presented at World CNS Summit
15 Mar 2018 2:10 pm
RNS
Results of Annual General Meeting
15 Feb 2018 7:00 am
RNS
Publication of Annual Report and Notice of AGM
14 Feb 2018 1:11 pm
RNS
Grant of Indian patent for EpiSwitch platform
30 Jan 2018 7:01 am
RNS
Shore Capital appointed as NOMAD and Sole Broker
  7:00 am
RNS
Final Results for the Year Ended 30 September 2017
29 Jan 2018 7:00 am
RNS
Collaboration in sports-related concussions
16 Jan 2018 7:00 am
RNS
Notice of Results
05 Jan 2018 3:05 pm
RNS
Holding(s) in Company
03 Jan 2018 7:00 am
RNS
Signs 2nd agreement with US biopharma company
02 Jan 2018 3:00 pm
RNS
Total Voting Rights
21 Dec 2017 7:00 am
RNS
Director/PDMR Shareholding
13 Dec 2017 7:01 am
RNS
Exercise period extension existing Share Options
05 Dec 2017 7:00 am
RNS
EXERCISE OF WARRANTS AND DIRECTOR DEALING
15 Nov 2017 7:00 am
RNS
Data at FNIH Biomarker Consortium Cancer Meeting
07 Nov 2017 7:00 am
RNS
Agreement with a major US biopharma company
06 Nov 2017 12:29 pm
RNS
Notification of major holdings
13 Oct 2017 7:00 am
RNS
Presents at the Diabetes Asia 2017 Conference
11 Oct 2017 7:00 am
RNS
Presents ALS signatures at NEALS
03 Oct 2017 7:00 am
RNS
Announces grant of US patent for EpiSwitchT
28 Sep 2017 7:00 am
RNS
Successful in diagnosing and staging breast cancer
15 Sep 2017 7:00 am
RNS
Directorate Update
30 Jun 2017 7:00 am
RNS
Appointment of Paul Stockdale as CFO
13 Jun 2017 7:00 am
RNS
Targets Amyotrophic Lateral Sclerosis in Asia
  7:00 am
RNS
Interim Results
31 May 2017 7:00 am
RNS
Publication highlights advantages of EpiSwitchT
  7:00 am
RNS
Notice of Interim Results
23 May 2017 7:00 am
RNS
Development Agreements with Top Pharma Companies
19 May 2017 7:00 am
RNS
Appointment of Shore Capital as Joint Broker
18 May 2017 7:00 am
RNS
Subsidiary signs exclusive Asia licence
 
Headlines
Top categories
Company finder
Forthcoming announcements

a d v e r t i s e m e n t